The American Society of Gene & Cell Therapy (ASGCT) is the primary membership organization for scientists, physicians, professionals, and patient advocates involved in gene and cell therapy.

Targeted genome editing technologies are being leveraged across many sectors including in the development of novel therapeutics.

The 2019 meeting will address DNA sequence variation and its role in molecular evolution, population genetics and complex diseases, comparative genomics, large-scale studies of gene and protein expression, and genomic approaches to ecological systems. Both technologies and applications will be emphasized. In addition there will be a special session on the ethical, legal and social implications (ELSI) of genome research.

Genome engineering has hit the streets. The plethora of new editing tools is propelling the field into the next genomic revolution. What are the new technologies? What will we make with them? How are the innovations impacting society and our individual lives? The Genome Writers Guild's annual conference highlights the fast pace of genomic engineering. Topics at the conference focus on recent research, tangible skills for the laboratory, and the challenges of social responsibility we all share.

The Symposium will include nine oral sessions and two poster sessions providing a current synthesis of the enormous progress in our understanding of the way RNA controls and regulates processes in the cell and organism, and how these mechanisms when aberrant may contribute to the progression of disease.

Since its inception in 2008, the annual CRISPR meeting has provided an international forum for scientists interested in all aspects of CRISPR-Cas systems, ranging from fundamental biology to biotechnological development, genome editing, and beyond. The primary goal of this meeting is to present state of the art novel research and global trends in CRISPR biology. CRISPR 2019 will continue the tradition of this unique scientific gathering, and will cover all aspects of CRISPR biology ranging from adaptation to interference, anti-CRISPR mechanisms, microbial tracking, and genome editing.

Fueled by the rapid advancements in both epigenetic research as [...]

This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

This symposium will particularly focus on translation medicine, and will be featuring speakers talking about gene editing, including those from Editas, Crispr Tx, Intellia and researchers from universities.

The main purpose of the International Mammalian Genome Society is to promote and stimulate research in mammalian genetics from sequencing to functional genomics, mutagenesis and mutant analysis, and to represent the concerns of its members in their professional activities. The company's activities have grown with the growing awareness of the important and unique role of rodent species in biomedical research and current genetics.

Conversations on Science, Society & the Future of Gene Editing CRISPRcon creates a unique forum in which a broad selection of diverse voices come together to discuss the future of CRISPR and related gene editing technologies across a variety of applications in agriculture, health, conservation and more.

The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms, together with scientists studying the basic biology of CRISPR-Cas and related bacterial defense systems.

ESGCT organises an Annual Congress, which brings together scientists working in the fields of gene and cell therapy from throughout Europe and beyond. The Congress is a platform for highlighting the latest research and techniques through the scientific sessions, which include keynote lectures, invited speakers, selected speakers, poster sessions and exhibitions.

This year's North American Cystic Fibrosis Conference (NACFC) will feature a wide variety of session formats.

The Liver Meeting® is the annual must-attend event bringing together 9,500 attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field.

The Gliwice Scientific Meeting is an annual event of international scope organized jointly by the Center of Oncology in Gliwice, Poland, together with the Silesian University of Technology. The Meetings are held under the auspices of the Association for the Support of Cancer Research, a local non-profit organization seeking progress in anticancer research.

The meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field and a global community of more than 25,000 hematology professionals from every subspecialty.

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

The Annual Conference of the IETS has emerged as the preeminent meeting in animal biotechnology, covering a broad area from embryo production and transfer techniques to cloning and transgenesis.

Genome editing is already transforming biological science and promises to do the same for human medicine. Technological capabilities are advancing rapidly and there are expected to be more than 30 genome editing therapies in clinical development by 2020. It is therefore important that practitioners in both academia and industry have the opportunity to learn about the latest improvements and applications.

TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home.

The International Mammalian Genome Society exists primarily to foster and stimulate research in mammalian genetics from sequencing and functional genomics to mutagenesis and mutant analysis, and to represent the concerns of its members in their professional activities. The activities of the society have expanded with the growing realization of the important and unique role of rodent species in current biomedical and genetic research.

The 2020 meeting will address DNA sequence variation and its role in molecular evolution, population genetics and complex diseases, comparative genomics, large-scale studies of gene and protein expression, and genomic approaches to ecological systems. Both technologies and applications will be emphasized. There will be a special session on the ethical, legal and social implications (ELSI) of genome research.

The fourth meeting on Regulatory & Non-Coding RNAs is going fully virtual and will now likely commence with a 10am morning session (US Eastern Time) on Tuesday, May 12 and the meeting will end with an afternoon session (Eastern Time)on Friday, May 15.

Join ASGCT in the heart of the biotech valley for the field's premier event, and take in the cutting edge of science with leaders from academia, medicine, industry, advocacy, and more.

Adenoviruses are associated with gastroenteritis, conjunctivitis, respiratory and urinary tract infections which in general have low clinical relevance. However, they can cause severe pathologies, even life-threatening, in immunosuppressed individuals. There is no efficient treatment for adenovirus infections approved so far. Adenoviruses can also produce serious disease in poultry and other domestic animals, resulting in economic losses. Remarkably, adenoviruses are also the most widely used vectors in the clinical gene therapy field.

CANCELLED

The Genome Writers Guild is a scientific organization of researchers, physicians, students, entrepreneurs, investors, government representatives, futurists, artists and the public. It is built on an understanding that genomic engineering comprises powerful technologies that have the potential to better humanity and the world humans inhabit.

The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms, together with scientists studying the basic biology of CRISPR and related bacterial defense systems.

Discovery on Target (DOT) is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. DOT highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

Bioproduction Summit brings together industry leaders and biotech experts to discuss most challenging issues, ranging from achieving high productivities to scalable platform processes.

This virtual conference will bring together leading experts in RNA editing and modifications, technology development, and medicine to present and discuss cutting edge research. We anticipate that participants of this conference will benefit from learning the cutting edge of the rapidly advancing field and help move the field forward by creating collaboration opportunities.

Fueled by the rapid advancements in both epigenetic research as well as translational gene editing and gene therapy, the EpiBio conferences were established in 2017 as a platform for synthetic biologists developing tools for epigenetic reprogramming.

The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.